TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Performance for the leading limb angle subtask
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: H-MRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neonatal APGAR score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: increased latent delivery stage without complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: NICU hospitalization in infants
Endpoint domain: Adverse events/effects
Primary endpoint: abdominal visceral fat area (AVFA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cognitive processing effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Patient perceived usefulness of the app
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient recommendation of the app
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Patient valuation of the app
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Peak perioperative SCl−
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cumulative incidence of Grade 2 or higher genitourinary toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative incidence of Grade 2 or higher gastrointestinal toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Mean urinary health-related quality of life (HRQOL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in hand cleanliness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of water and soap in handwashing station
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in visible feces on latrine slab or floor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AEA concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nursing satisfaction with monitoring
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean number of side effects reported
Endpoint domain: Adverse events/effects
Primary endpoint: Supplementation compliance (ingestion for 90+ days)
Endpoint domain: Adverse events/effects
Primary endpoint: emotional responses
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: cognitive distortions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Investigator Global Assessment for AD score of 0/1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained MMS with complete withdrawal of prednisone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stroop test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Yo‐Yo IR1 test distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brad Johnson goalkicking test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Blood Alcohol Concentration (BAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reductions in drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive performance of therapeutic drug monitoring of vancomycin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 3-month birth control use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Coefficient of variation for the HOMA-IR index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Thoracic Kyphosis Angle (TKA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lumbar Lordosis Angle (LLA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative renal failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: GDS-15 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-minute walk distance (6MWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Energy bioaccessibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fat bioaccessibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 6-sulfatoxymelatonin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in lung function (FEV1 % predicted)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline in morning peak expiratory flow (PEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Development of sacral pressure injury (PI)
Endpoint domain: Adverse events/effects
Primary endpoint: Acute hemodynamic response (dP/dtmax ≥10%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reverse remodeling at 6 months (LV end-systolic volume improvement ≥15%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Self-efficacy to regulate stress and anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Statistically significant increase in SOL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful discharge from the hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Accuracy of self-reported healthcare utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of affected teeth with MIH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Incremental AUC of gastric antrum CSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with curds ≥20 mm with high echogenicity clot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shoulder abduction mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Osteocalcin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total difficulties
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CW compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TNSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean utility increase
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: ICER gain
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Plasma GDF-15 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRC-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RFcsa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: reduction in body mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: increase in self-reported physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: relief of posttraumatic headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain reduction during LEEP procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean STS change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with improvement of 10 mm or more in STS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of satisfaction with analgesia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acute success rate of AF termination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AF/AT-free survival after repeat ablation procedures
Endpoint domain: Mortality/survival
Primary endpoint: Errors in clinical quality reporting
Endpoint domain: Adverse events/effects
Primary endpoint: Mean daily step increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: captured opportunities to complete the primary series
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: up-to-date immunization overall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to Glittre-ADL test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Consciousness (LOC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Health Component (PHC) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mental Health Component (MHC) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prevalence of drug resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Multi-class resistance rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Understanding of concepts discussed
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Trust in clinician
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean velocity performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No Evidence of Disease Activity-3 (NEDA-3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRI outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of asthma worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elevated liver aminotransferase levels
Endpoint domain: Adverse events/effects
Primary endpoint: PTSD symptoms one month after intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Distress relief immediately after intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean overall costs per year for patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean overall costs per year for caregivers
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Productivity loss costs associated with fatigue
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ED50 and ED95 values for epidural dexmedetomidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative uveitis recurrences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of recurrences per eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified VASI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-selected wattage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total work during cycling session
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Volunteers' experiences in providing support
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: distance covered on the Yoyo IR1 test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pathologist-measured biopsy length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biopsy quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median ITI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average respiratory rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Frequency of smoking per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FTCD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in CPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IgG antibody detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Overall image quality of nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brushing and flossing behaviours
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Microleakage penetration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sPGA score 0 or 1 achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes in subjective norms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: COMBO in-segment LLL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Readmissions within 6 months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: standardized assessment use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of cats with at least 1 adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: prevalence of iron deficiency anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of patients with a pathological complete response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychiatric symptomatology
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: local recurrence risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: mortality from other causes
Endpoint domain: Mortality/survival
Primary endpoint: Pregnancy Pressure Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of participants using video visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean lateral tibial slope angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of CE-events
Endpoint domain: Adverse events/effects
Primary endpoint: Likelihood of receiving a kidney transplant
Endpoint domain: Mortality/survival
Primary endpoint: Depression scores at 6-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety symptoms at 6-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scapula retraction improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in breast motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Scapula depression improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximal voluntary isometric contraction decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Nighttime SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Nighttime pulse rate (PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with abnormal BP circadian rhythms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Duration of combined radical resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of neck complications
Endpoint domain: Adverse events/effects
Primary endpoint: NRPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: active cervical rotation towards the opposite arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving vIGA-AD (0,1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of 75% or more in the EASI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving itch NRS improvement ≥ 4 points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of complete recovery of LV remodelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of LV remodelling relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Allogeneic red blood cell transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of postoperative seizure, thrombotic events, kidney dysfunction, and death
Endpoint domain: Adverse events/effects
Primary endpoint: VLQ values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of fibroblasts, blood vessels, and fatty degeneration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: type III collagen and vimentin expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of moderate exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: psychological need satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: subjective vitality
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: percentage of individuals achieving ≥5% weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean HbA1c reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain threshold of newborns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rates of newborns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen saturation levels in newborns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in spiritual well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in feelings of sadness and depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in caregiver burden
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: mHRQOL improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: faecal concentrations of total SCFA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bifidogenic effect on Bifidobacterium adolescentis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anesthesia-related cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Benefit of high-dose chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean VEGF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in thrombospondin‐1 from baseline to A2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Narrative immersion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Risk of diarrhoea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of patients with APN
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: First-attempt success rate of catheter tip location
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of total complications
Endpoint domain: Adverse events/effects
Primary endpoint: hip pain improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hip function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in overall presentations to emergency departments
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Trend for lower hospitalizations due to psychosis
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: pain absence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: heart rate mean
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of young adults achieving 10% weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative menstrual attitudes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum muscular strength for the knee extensor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Low Birth Weight (LBW) neonate proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Incidence rate of secondary posttonsillectomy haemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Need for re-hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Average SBP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes